Johnson & Johnson said the U.S. Food and Drug Administration approved its iDESIGN refractive studio system used in laser eye surgery for treating certain vision conditions.

The New Brunswick, N.J.-based company's unit Johnson & Johnson Vision Care, Inc. said the system is used to treat myopia, hyperopia and mixed astigmatism — a condition causing blurred vision.

Johnson & Johnson said the system will allow doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure that is personalized for each patient.

In addition, the company said the iDESIGN system is the only available LASIK platform used for monovision in presbyopic myopic patients.

Monovision is a procedure for patients over 40 years of age who experience blurry near vision due to the aging of their eyes.